fda banned semaglutide Fifth Circuit probes ban on compounded GLP-1s Compounded Semaglutide: Is It Still

Then, Novo Nordisk completed the phase 3 trial of high-dose semaglutide to treat obesity and won the FDA approval for obesity treatment in June

While some people may choose to stay on semaglutide long-term to maintain benefits like weight loss and blood sugar control, others may stop if goals are reached and maintained through lifestyle changes

You can change your day temporarily for one week, or make the change permanent

This pharmacological agent, initially developed for the management of type 2 diabetes mellitus , has shown promising results in weight loss, sparking interest and debate in medicine

Read more about our editorial policies here